Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moritz Koch

Showing results (81-90 of 115) with videos related to

Pageof 12
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|March 24, 2010
In colorectal cancer mast cells contribute to systemic regulatory T-cell dysfunctionNichole R Blatner, Andreas Bonertz, Philipp Beckhove, et al.
Annals of Surgical Oncology|June 4, 2008
Detection and functional analysis of tumor infiltrating T-lymphocytes (TIL) in liver metastases from colorectal cancerPhilipp Wagner, Moritz Koch, Daniel Nummer, et al.
Annals of Surgery|October 27, 2015
Metastatic Spread Emerging From Liver Metastases of Colorectal Cancer: Does the Seed Leave the Soil Again?Nuh N Rahbari, Ulrich Bork, Sebastian Schölch, et al.
Surgery|December 21, 2005
Expression of cytokeratin-20 in pancreatic cancer: an indicator of poor outcome after R0 resectionFriedrich Hubertus Schmitz-Winnenthal, Christine Volk, Burckhard Helmke, et al.
Cancer Research|January 28, 2010
RETRACTED: Variable inhibition of thrombospondin 1 against liver and lung metastases through differential activation of metalloproteinase ADAMTS1Yoon-Jin Lee, Moritz Koch, Daniel Karl, et al.
Annals of Surgery|March 18, 2011
Infrahepatic inferior vena cava clamping for reduction of central venous pressure and blood loss during hepatic resection: a randomized controlled trialNuh N Rahbari, Moritz Koch, Johannes B Zimmermann, et al.
Pathology|March 26, 2011
A gene signature distinguishing CD133hi from CD133- colorectal cancer cells: essential role for EGR1 and downstream factorsAurélie Ernst, Maximilian Aigner, Susumu Nakata, et al.
Therapeutic Advances in Neurological Disorders|May 5, 2021
Switch from intravenous to subcutaneous immunoglobulin IgPro20 in CIDP patients: a prospective observational study under real-world conditionsStefan Gingele, Moritz Koch, Anna Christina Saparilla, et al.
BMC Cancer|April 7, 2012
Resection of the primary tumour versus no resection prior to systemic therapy in patients with colon cancer and synchronous unresectable metastases (UICC stage IV): SYNCHRONOUS--a randomised controlled multicentre trial (ISRCTN30964555)Nuh N Rahbari, Florian Lordick, Christine Fink, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 18, 2011
Natural killer cells are scarce in colorectal carcinoma tissue despite high levels of chemokines and cytokinesNiels Halama, Monika Braun, Christoph Kahlert, et al.
Pageof 12

Showing results (81-90 of 115) with videos related to

Sort By:
Pageof 12
Proceedings of the National Academy of Sciences of the United States of America|March 24, 2010
In colorectal cancer mast cells contribute to systemic regulatory T-cell dysfunctionNichole R Blatner, Andreas Bonertz, Philipp Beckhove, et al.
Annals of Surgical Oncology|June 4, 2008
Detection and functional analysis of tumor infiltrating T-lymphocytes (TIL) in liver metastases from colorectal cancerPhilipp Wagner, Moritz Koch, Daniel Nummer, et al.
Annals of Surgery|October 27, 2015
Metastatic Spread Emerging From Liver Metastases of Colorectal Cancer: Does the Seed Leave the Soil Again?Nuh N Rahbari, Ulrich Bork, Sebastian Schölch, et al.
Surgery|December 21, 2005
Expression of cytokeratin-20 in pancreatic cancer: an indicator of poor outcome after R0 resectionFriedrich Hubertus Schmitz-Winnenthal, Christine Volk, Burckhard Helmke, et al.
Cancer Research|January 28, 2010
RETRACTED: Variable inhibition of thrombospondin 1 against liver and lung metastases through differential activation of metalloproteinase ADAMTS1Yoon-Jin Lee, Moritz Koch, Daniel Karl, et al.
Annals of Surgery|March 18, 2011
Infrahepatic inferior vena cava clamping for reduction of central venous pressure and blood loss during hepatic resection: a randomized controlled trialNuh N Rahbari, Moritz Koch, Johannes B Zimmermann, et al.
Pathology|March 26, 2011
A gene signature distinguishing CD133hi from CD133- colorectal cancer cells: essential role for EGR1 and downstream factorsAurélie Ernst, Maximilian Aigner, Susumu Nakata, et al.
Therapeutic Advances in Neurological Disorders|May 5, 2021
Switch from intravenous to subcutaneous immunoglobulin IgPro20 in CIDP patients: a prospective observational study under real-world conditionsStefan Gingele, Moritz Koch, Anna Christina Saparilla, et al.
BMC Cancer|April 7, 2012
Resection of the primary tumour versus no resection prior to systemic therapy in patients with colon cancer and synchronous unresectable metastases (UICC stage IV): SYNCHRONOUS--a randomised controlled multicentre trial (ISRCTN30964555)Nuh N Rahbari, Florian Lordick, Christine Fink, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 18, 2011
Natural killer cells are scarce in colorectal carcinoma tissue despite high levels of chemokines and cytokinesNiels Halama, Monika Braun, Christoph Kahlert, et al.
Pageof 12